Literature DB >> 9245856

Effect of growth hormone on fatty liver in panhypopituitarism.

S Takano1, S Kanzaki, M Sato, T Kubo, Y Seino.   

Abstract

A 17 year old boy was admitted because of short stature and hepatomegaly. He was diagnosed with panhypopituitarism and fatty liver. The fatty liver improved, not with hydrocortisone or levothyroxine treatment, but with growth hormone administration. The fatty liver in this patient was attributable to a growth hormone deficient state.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9245856      PMCID： PMC1717220          DOI： 10.1136/adc.76.6.537

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  Metabolic effects of growth hormone in children.

Authors:  H A Wollmann; M B Ranke
Journal:  Metabolism       Date:  1995-10       Impact factor: 8.694

Review 2.  In vitro effects of growth hormone in adipose tissue.

Authors:  M Wabitsch; H Hauner; E Heinze; W Teller
Journal:  Acta Paediatr Suppl       Date:  1994-12

3.  Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.

Authors:  J Hellmér; C Marcus; T Sonnenfeld; P Arner
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

4.  Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.

Authors:  Z Laron; S Anin; Y Klipper-Aurbach; B Klinger
Journal:  Lancet       Date:  1992-05-23       Impact factor: 79.321

5.  Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children.

Authors:  M Rosenbaum; J M Gertner; R L Leibel
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

6.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

Authors:  F Salomon; R C Cuneo; R Hesp; P H Sönksen
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245
  6 in total
  14 in total

1.  Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment.

Authors:  Carlos M Reyes-Vidal; Hamed Mojahed; Wei Shen; Zhezhen Jin; Fernando Arias-Mendoza; Jean Carlos Fernandez; Dympna Gallagher; Jeffrey N Bruce; Kalmon D Post; Pamela U Freda
Journal:  J Clin Endocrinol Metab       Date:  2015-06-02       Impact factor: 5.958

2.  Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats.

Authors:  Ying Qin; Ya-ping Tian
Journal:  Lipids Health Dis       Date:  2010-07-26       Impact factor: 3.876

3.  [Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction].

Authors:  D Goltz; K Schötta; H Zhou; H-P Fischer
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

Review 4.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

5.  Nonalcoholic Fatty liver disease and metabolic syndrome in hypopituitary patients.

Authors:  Ebenezer A Nyenwe; Sarah Williamson-Baddorf; Bradford Waters; Jim Y Wan; Solomon S Solomon
Journal:  Am J Med Sci       Date:  2009-09       Impact factor: 2.378

6.  Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report.

Authors:  Ayumu Takeno; Masahiro Yamamoto; Masakazu Notsu; Toshitsugu Sugimoto
Journal:  BMC Endocr Disord       Date:  2016-11-24       Impact factor: 2.763

7.  Type 2 Diabetes Mellitus, a Sequel of Untreated Childhood Onset Growth Hormone Deficiency Developing in a 17-Year-Old Patient.

Authors:  Rohan K Henry; Ram K Menon
Journal:  Case Rep Endocrinol       Date:  2018-10-24

8.  Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly.

Authors:  Adriana P Kuker; Wei Shen; Zhezhen Jin; Simran Singh; Jun Chen; Jeffrey N Bruce; Pamela U Freda
Journal:  J Endocr Soc       Date:  2021-02-01

Review 9.  The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver.

Authors:  Yutaka Takahashi
Journal:  Int J Mol Sci       Date:  2017-07-05       Impact factor: 5.923

10.  Somatotropic Axis and Obesity: Is There Any Role for the Mediterranean Diet?

Authors:  Giovanna Muscogiuri; Luigi Barrea; Daniela Laudisio; Carolina Di Somma; Gabriella Pugliese; Ciro Salzano; Annamaria Colao; Silvia Savastano
Journal:  Nutrients       Date:  2019-09-16       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.